Identifying and optimizing small molecules for reproductive health and contraception
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - SCALABLE QUANTITIES
['FUNDING_OTHER'] · SRI INTERNATIONAL · NIH-10942882
This study is looking for new small molecules that could help with birth control and improve reproductive health, aiming to create better treatments for issues like infertility, endometriosis, and premature birth, so that patients can have more options for their health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SRI INTERNATIONAL (nih funded) |
| Locations | 1 site (MENLO PARK, UNITED STATES) |
| Trial ID | NIH-10942882 on ClinicalTrials.gov |
What this research studies
This research focuses on the identification and optimization of small molecules that can be used for contraceptive purposes and to improve reproductive health. The Chemical Screening and Optimization Facility (CSOF) will conduct scalable projects to produce these molecules, which may address various conditions such as infertility, endometriosis, and premature birth. The methodology includes generating and purifying these compounds, ensuring their quality through advanced analytical techniques. Patients may benefit from new treatments that enhance reproductive health and address related conditions.
Who could benefit from this research
Good fit: Ideal candidates include individuals experiencing reproductive health challenges such as infertility, endometriosis, or those seeking contraceptive options.
Not a fit: Patients with unrelated health conditions or those not seeking reproductive health interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new contraceptive methods and treatments for various reproductive health issues.
How similar studies have performed: Previous research has shown promise in developing small molecules for reproductive health, indicating potential for success in this area.
Where this research is happening
MENLO PARK, UNITED STATES
- SRI INTERNATIONAL — MENLO PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GONG, LEYI — SRI INTERNATIONAL
- Study coordinator: GONG, LEYI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cushing Disease, Pituitary-dependent Cushing's disorder, Pituitary-dependent Cushing's disease